News & Sentiment
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,782 articles
📰
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) reached $6.16 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.
📰
UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, UnitedHealth Group (UNH) closed at $379.09, marking a -2.37% move from the previous day.
📰
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
Adma Biologics (ADMA) reached $9.23 at the closing of the latest trading day, reflecting a -1.7% change compared to its last close.
📰
Novavax (NVAX) Laps the Stock Market: Here's Why
In the most recent trading session, Novavax (NVAX) closed at $9.42, indicating a +1.29% shift from the previous trading day.
📰
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000
The executive liquidated his entire direct holdings as the stock plunged about 50% from its 52-week high.
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
📰
1 Thing I Wish I'd Known About the Stock Market When I First Started Investing
What is the most expensive habit a new investor can pick up? Taking quick profits on a company worth owning for decades.
📰
Could This New Opportunity Be Worth Billions for Novo Nordisk?
The worst may be in the rearview mirror for the drugmaker.
📰
Wall Street Marks 25 Years Since 9/11
Get a jump start on the US trading day with Vonnie Quinn and Michael Mckee on "Bloomberg Open Interest." Twenty-five years after September 11th,...
📰
Sanofi: Information concerning the total number of voting rights and shares - August 2026 - Yahoo Finance
Sanofi: Information concerning the total number of voting rights and shares - August 2026 Yahoo Finance
Can Centene's Medicare Advantage Strategy Unlock Better Margins?
CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.